title: High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma.
abstract: Telomere length is maintained by two known mechanisms, activation of telomerase or alternative lengthening of telomeres (ALT). The ALT pathway is more commonly activated in tumours of mesenchymal origin, although the mechanisms involved in the decision of a cell to activate either telomerase or ALT are unknown at present and no molecular markers exist to define the ALT phenotype. We have previously shown an association between chromatin remodelling, telomerase gene expression and ALT in cell line models. Here, we evaluate these findings and investigate their prognostic significance in a panel of liposarcoma tissue samples to understand the biology underlying the ALT phenotype. Liposarcoma samples were split into three groups: telomerase positive (Tel+); ALT positive; ALT-/Tel-. Differences in telomerase gene expression were evident between the groups with increased expression of hTR in ALT and Tel+ compared to ALT-/Tel- samples and increased hTERT in Tel+ samples only. Investigation of a small panel of chromatin modifications revealed significantly increased binding of acetyl H3 in association with hTR expression. We confirm that the presence of the ALT phenotype is associated with poor prognosis and in addition, for the first time, we show a direct association between hTR expression and poor prognosis in liposarcoma patients.
authors.affiliation: Centre for Oncology and Applied Pharmacology, University of Glasgow, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.
authors.forename: C J
authors.initials: CJ
authors.lastname: Cairney
authors.forename: S F
authors.initials: SF
authors.lastname: Hoare
authors.forename: M-G
authors.initials: MG
authors.lastname: Daidone
authors.forename: N
authors.initials: N
authors.lastname: Zaffaroni
authors.forename: W N
authors.initials: WN
authors.lastname: Keith
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002843:Chromatin / Q000378:metabolism*; D047369:Chromatin Immunoprecipitation; D005260:Female; D006657:Histones / Q000378:metabolism; D006801:Humans; D008080:Liposarcoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011401:Promoter Regions, Genetic; D012313:RNA / Q000235:genetics*; D019098:Telomerase / Q000235:genetics*; D016615:Telomere
chemical_list: D002843:Chromatin; D006657:Histones; C422952:telomerase RNA; D012313:RNA; C509186:TERT protein, human; D019098:Telomerase